ANI Pharmaceuticals

ANI Pharmaceuticals ANIP Stock

$79.20   -1.074200%
Add to favorites
Market Cap
$1.80B
LOW - HIGH [24H]
$79.10 - $80.93
VOLUME [24H]
$289.47K
P/E Ratio
20.41
Earnings per share
$3.88
ISIN
US00182C1036
Price   Prediction

ANI Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

ANI Pharmaceuticals ANIP Financial and Trading Overview

ANI Pharmaceuticals stock price 79.2 USD
Previous Close 80.43 USD
Open 79.65 USD
Bid 56.99 USD x 200
Ask 102.48 USD x 200
Day's Range 78.28 - 80.38 USD
52 Week Range 63.67 - 99.5 USD
Volume 205.18K USD
Avg. Volume 341.02K USD
Market Cap 1.8B USD
Beta (5Y Monthly) 0.464
PE Ratio (TTM) 20.265984
EPS (TTM) 3.88 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 110 USD

ANIP Valuation Measures

Enterprise Value 1.98B USD
Trailing P/E 20.265984
Forward P/E 7.3646336
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.9502863
Price/Book (mrq) 3.008238
Enterprise Value/Revenue 2.148
Enterprise Value/EBITDA 10.054

Trading Information

ANI Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.464
52-Week Change 21.10%
S&P500 52-Week Change 18.32%
52 Week High 99.5 USD
52 Week Low 63.67 USD
50-Day Moving Average 81.11 USD
200-Day Moving Average 81.24 USD

ANIP Share Statistics

Avg. Volume (3 month) 341.02K USD
Avg. Daily Volume (10-Days) 249.14K USD
Shares Outstanding 22.73M
Float 19.42M
Short Ratio 9.99
% Held by Insiders 5.51%
% Held by Institutions 110.96%
Shares Short 3.37M
Short % of Float 18.10%
Short % of Shares Outstanding 14.82%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:6

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) March 31, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 9.97%
Operating Margin (ttm) 16.29%
Gross Margin 60.82%
EBITDA Margin 21.36%

Management Effectiveness

Return on Assets (ttm) 4.96%
Return on Equity (ttm) 18.32%

Income Statement

Revenue (ttm) 923.71M USD
Revenue Per Share (ttm) 45.33 USD
Quarterly Revenue Growth (yoy) 20.50%
Gross Profit (ttm) 561.85M USD
EBITDA 197.38M USD
Net Income Avi to Common (ttm) 83.94M USD
Diluted EPS (ttm) 3.91
Quarterly Earnings Growth (yoy) 88.09%

Balance Sheet

Total Cash (mrq) 326.06M USD
Total Cash Per Share (mrq) 15.38 USD
Total Debt (mrq) 630.21M USD
Total Debt/Equity (mrq) 112.08 USD
Current Ratio (mrq) 3.119
Book Value Per Share (mrq) 26.341

Cash Flow Statement

Operating Cash Flow (ttm) 208.61M USD
Levered Free Cash Flow (ttm) 140.26M USD

Profile of ANI Pharmaceuticals

Country United States
State MN
City Baudette
Address 210 Main Street West
ZIP 56623
Phone 218 634 3500
Website https://www.anipharmaceuticals.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 970

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Q&A For ANI Pharmaceuticals Stock

What is a current ANIP stock price?

ANI Pharmaceuticals ANIP stock price today per share is 79.2 USD.

How to purchase ANI Pharmaceuticals stock?

You can buy ANIP shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ANI Pharmaceuticals?

The stock symbol or ticker of ANI Pharmaceuticals is ANIP.

Which industry does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.

How many shares does ANI Pharmaceuticals have in circulation?

The max supply of ANI Pharmaceuticals shares is 22.73M.

What is ANI Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

ANI Pharmaceuticals PE Ratio is 20.41237000 now.

What was ANI Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

ANI Pharmaceuticals EPS is 3.88 USD over the trailing 12 months.

Which sector does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals sector is Healthcare.

ANI Pharmaceuticals ANIP included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 26584.99 USD
+2.59
8.76B USD 26088.04 USD 26679.91 USD 8.76B USD
us US Tech Composite Total Return XCMP US 32799.34 USD
+2.59
32186.23 USD 32916.44 USD
us Stlmt ID US Tech Biotechnology NBX US 3995.9 USD
-4.37
4555.41 USD 4917.8 USD
us US Tech Biotechnology Total Retu XNBI US 7179.54 USD
+2.29
7037.03 USD 7185.28 USD
us US Tech Global Market Composite NQGM US 2306.18 USD
+3.17
2260.25 USD 2312.49 USD
us US Tech Biotechnology NBI US 6578.45 USD
+2.29
6447.87 USD 6583.71 USD
us US Tech Health Care IXHC US 1263.73 USD
+1.81
1242.12 USD 1264.81 USD
$2.27T
Total marketcap
$54.03B
Total volume
BTC 56.58%     ETH 9.90%
Dominance
Select currency